[
  {
    "ts": "2026-01-16T13:15:00+00:00",
    "headline": "Arch Biopartners Announces Appointment of Dr. Patrick Vink as Chairman of the Board",
    "summary": "TORONTO, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today the appointment of Dr. Patrick Vink as Chairman of the Company’s Board of Directors, effective January 15, 2026. Dr. Vink, M.D., M.B.A., has been an advisor to the pharmaceutical industry since 2015 and has served as a non-executive board member or chair of several public and private companies in North America and Europe. He has overseen or supported sev",
    "url": "https://finance.yahoo.com/news/arch-biopartners-announces-appointment-dr-131500179.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "d78bf642-448c-3d49-82c3-6bf2101a186c",
      "content": {
        "id": "d78bf642-448c-3d49-82c3-6bf2101a186c",
        "contentType": "STORY",
        "title": "Arch Biopartners Announces Appointment of Dr. Patrick Vink as Chairman of the Board",
        "description": "",
        "summary": "TORONTO, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today the appointment of Dr. Patrick Vink as Chairman of the Company’s Board of Directors, effective January 15, 2026. Dr. Vink, M.D., M.B.A., has been an advisor to the pharmaceutical industry since 2015 and has served as a non-executive board member or chair of several public and private companies in North America and Europe. He has overseen or supported sev",
        "pubDate": "2026-01-16T13:15:00Z",
        "displayTime": "2026-01-16T13:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/82959c7ebf37ffabc22c5203017c1615",
          "originalWidth": 300,
          "originalHeight": 153,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BXjjRm5GB6boZWMUiYJy6w--~B/aD0xNTM7dz0zMDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/82959c7ebf37ffabc22c5203017c1615.cf.webp",
              "width": 300,
              "height": 153,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_AVb5OGBx9YfztjZqMzIkg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/82959c7ebf37ffabc22c5203017c1615.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/arch-biopartners-announces-appointment-dr-131500179.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/arch-biopartners-announces-appointment-dr-131500179.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ACHFF"
            },
            {
              "symbol": "BRKR"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]